Cardiovascular and diabetes burden attributable to physical inactivity in Mexico.
Cardiovascular diseases
Mexico
Mortality
Physical inactivity
Type 2 diabetes
Journal
Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637
Informations de publication
Date de publication:
29 06 2020
29 06 2020
Historique:
received:
06
02
2020
accepted:
05
06
2020
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
27
10
2020
Statut:
epublish
Résumé
Physical inactivity (PI) is associated with the development of non-communicable chronic diseases. The purposes of this study were to estimate the extent to which the 31% relative increase in PI among 35-64 years old Mexicans between 2006 and 2012 influenced diabetes (T2D) and cardiovascular disease (CVD) incidence and mortality, and to estimate the impact of the World Health Organization recommended 10% and 15% relative decrease in PI on CVD and T2D incidence and mortality by 2025 and 2030, respectively. Estimates were derived using the Cardiovascular Disease Policy Model-Mexico, a computer simulation, Markov model. Model inputs included cross-national data on PI levels from 2006 and 2012 measured using the International Physical Activity Questionnaire and the published literature review on the independent relationship between PI and cardiometabolic risk. The models estimated that the 31% increase in PI resulted in an increase in the number of cases of T2D (27,100), coronary heart disease (10,300), stroke (2200), myocardial infarction (1500), stroke deaths (400) and coronary heart disease deaths (350). A hypothetical 10% lowering of PI by 2025 compared to status quo is projected to prevent 8400 cases of T2D, 4200 cases of CHD, 1000 cases of stroke, 700 cases of MI, and 200 deaths of CHD and stroke, respectively. A 15% reduction resulted in larger decreases. While the burden of T2D and CVD raised from 2006 to 2012 in association with increased PI, achieving the WHO targets by 2030 could help reverse these trends.
Sections du résumé
BACKGROUND
Physical inactivity (PI) is associated with the development of non-communicable chronic diseases. The purposes of this study were to estimate the extent to which the 31% relative increase in PI among 35-64 years old Mexicans between 2006 and 2012 influenced diabetes (T2D) and cardiovascular disease (CVD) incidence and mortality, and to estimate the impact of the World Health Organization recommended 10% and 15% relative decrease in PI on CVD and T2D incidence and mortality by 2025 and 2030, respectively.
METHODS
Estimates were derived using the Cardiovascular Disease Policy Model-Mexico, a computer simulation, Markov model. Model inputs included cross-national data on PI levels from 2006 and 2012 measured using the International Physical Activity Questionnaire and the published literature review on the independent relationship between PI and cardiometabolic risk.
RESULTS
The models estimated that the 31% increase in PI resulted in an increase in the number of cases of T2D (27,100), coronary heart disease (10,300), stroke (2200), myocardial infarction (1500), stroke deaths (400) and coronary heart disease deaths (350). A hypothetical 10% lowering of PI by 2025 compared to status quo is projected to prevent 8400 cases of T2D, 4200 cases of CHD, 1000 cases of stroke, 700 cases of MI, and 200 deaths of CHD and stroke, respectively. A 15% reduction resulted in larger decreases.
CONCLUSIONS
While the burden of T2D and CVD raised from 2006 to 2012 in association with increased PI, achieving the WHO targets by 2030 could help reverse these trends.
Identifiants
pubmed: 32600339
doi: 10.1186/s12933-020-01050-3
pii: 10.1186/s12933-020-01050-3
pmc: PMC7325101
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
99Subventions
Organisme : FIC NIH HHS
ID : R03 TW009061
Pays : United States
Références
CMAJ. 2000 Nov 28;163(11):1435-40
pubmed: 11192648
Am J Public Health. 1987 Nov;77(11):1417-26
pubmed: 3661794
Int J Behav Nutr Phys Act. 2011 Sep 24;8:99
pubmed: 21943093
J Am Coll Cardiol. 2002 Dec 4;40(11):1902-14
pubmed: 12475448
Lancet. 2012 Jul 21;380(9838):247-57
pubmed: 22818937
Rev Panam Salud Publica. 2013 Jul;34(1):21-8
pubmed: 24006016
N Engl J Med. 1999 Nov 4;341(19):1413-9
pubmed: 10547403
Salud Publica Mex. 2018 May-Jun;60(3):233-243
pubmed: 29746740
JAMA. 2018 Nov 20;320(19):2020-2028
pubmed: 30418471
Circulation. 2011 Aug 16;124(7):789-95
pubmed: 21810663
Lancet. 2016 Nov 12;388(10058):2386-2402
pubmed: 27720260
Br J Sports Med. 2003 Jun;37(3):197-206; discussion 206
pubmed: 12782543
PLoS Med. 2016 Nov 1;13(11):e1002158
pubmed: 27802278
Curr Diab Rep. 2019 Jun 20;19(7):44
pubmed: 31222515
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Rev Salud Publica (Bogota). 2006 Dec;8 Suppl 2:28-41
pubmed: 17361576
Salud Publica Mex. 2018 May-Jun;60(3):224-232
pubmed: 29746739
Lancet Neurol. 2016 Aug;15(9):913-924
pubmed: 27291521
Salud Publica Mex. 2013;55 Suppl 2:S332-40
pubmed: 24626712
BMC Public Health. 2013 Nov 11;13:1063
pubmed: 24215173
BMJ. 2016 Aug 09;354:i3857
pubmed: 27510511